Key dates

  • November 2019 – AbolerIS Pharma is founded by Dr. Carole Guillonneau (Director of Research CNRS) and Dr. Ignacio Anegon (Director of Research INSERM) and Dr. François-Xavier Hubert (MD, PhD).

  • November 2020 – AbolerIS Pharma raises 2,5M$ in Seed Financing from Newton Biocapital and Turenne Santé/Sham Innovation Santé.

Press Releases

  • 15/12/2020 – AbolerIS Pharma’s co-founder Dr. Carole Guillonneau receives Albert Sezary Prize from the National Academy of Medicine. Read in English. Read in French
  • 01/12/2020 – AbolerIS Pharma signed an exclusive world-wide license with Ouest Valorisation to develop new first-in-class anti-CD45RC antibodies. Read in English . Read in French.
  • 04/11/2020 – AbolerIS Pharma Raises €2.5M in Seed Financing from Newton Biocapital and Turenne Santé/Sham Innovation Santé. Read in English . Read in French.

Events

New dates to come soon.